Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Stibogluconate (Pentostam) for Leishmaniasis
NCT00657618Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Oct 2004
- Primary completion
- Apr 2010
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sodium stibogluconate in leishmaniasis, sponsored by U.S. Army Medical Research and Development Command. Started Oct 2004; status: completed.
02
Drugs
sodium stibogluconate
03
Conditions
leishmaniasis
Beyond the preview
Go deeper on NCT00657618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657618.